サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1795318

前臨床呼吸・吸入実験装置の世界市場

Preclinical Respiration and Inhalation Lab Equipment

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
前臨床呼吸・吸入実験装置の世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

前臨床呼吸・吸入実験装置の世界市場は2030年までに2,600万米ドルに達する見込み

2024年に2,030万米ドルと推定される前臨床呼吸・吸入実験装置の世界市場は、分析期間2024-2030年にCAGR 4.3%で成長し、2030年には2,600万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである呼吸装置は、CAGR 4.9%を記録し、分析期間終了までに1,820万米ドルに達すると予測されます。吸入装置セグメントの成長率は、分析期間でCAGR 2.8％と推定されます。

米国市場は530万米ドルと推定、中国はCAGR4.2％で成長予測

米国の前臨床呼吸・吸入実験装置市場は2024年に530万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに420万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.0％と3.7％と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界の前臨床呼吸・吸入実験装置市場- 主要動向と促進要因のまとめ

呼吸器系および吸入系試験の精度とスループットを高めるテクノロジーとは？

前臨床呼吸・吸入実験装置は、測定精度、暴露制御、生物学的モデリングの向上のため、急速に技術改良が進んでいます。プレチスモグラフィーシステム、全身暴露チャンバー、鼻専用暴露塔、エアロゾル発生装置の進歩により、研究者はより高精度で一貫性のあるヒト吸入シナリオのシミュレーションが可能になっています。これらのシステムは現在、高解像度の圧力センサー、差動流量計、およびリアルタイムのデータ収集ソフトウェアを統合しており、意識のあるげっ歯類や麻酔をかけた被験者の潮容積、呼吸数、分時換気量、およびピーク呼気流量をモニターすることができます。

エアロゾルデリバリーシステムは、スマートパーティクル・サイザー、高周波超音波ネブライザー、マスフローコントローラーによって進化しており、呼吸器のさまざまな領域にわたって再現性のある粒子沈着を可能にしています。新しいシステムはまた、生理学的に適切なエアロゾル調整のための加湿と温度調節を組み込んでいます。自動サンプリングとテレメトリー対応システムは、呼吸器バイオマーカーの収集、ガス交換測定の実施、薬剤候補や環境毒素に反応した呼吸抑制や肺刺激性のモニターに使用されています。これらの技術は、前臨床薬物動態学、毒物学、吸入治療薬開発パイプラインにおける急性および慢性暴露プロトコルの両方をサポートします。

どの研究領域で前臨床呼吸装置の使用が拡大しているか？

前臨床呼吸装置は肺のドラッグデリバリー研究で長い間使用されてきましたが、その用途はいくつかの学際的な領域で拡大しています。呼吸器内科の研究開発では、喘息、COPD、嚢胞性線維症、特発性肺線維症に対する吸入コルチコステロイド、気管支拡張剤、新規生物製剤の有効性と安全性を評価する上で、これらのシステムが中心となっています。腫瘍学では、化学療法剤送達のための吸入製剤が、気管内および鼻腔内投与装置によってサポートされながら、肺腫瘍における部位特異的沈着について試験されています。

この装置はまた、大気汚染物質、ナノ粒子、工業化学物質による吸入毒性を評価するための環境衛生研究にも使用されています。OECDや米国環境保護庁（EPA）などの規制機関は、化学物質のリスク評価に関するガイドラインにおいて、吸入暴露試験をますます重視するようになっています。さらに、感染症研究者は、SARS-CoV-2、インフルエンザ、結核を含む空気中のウイルスやバクテリアの感染や呼吸器への影響を評価するために、鼻専用の暴露室やエアロゾル化病原体システムを採用しています。リアルタイムの呼吸遠隔測定とバイオセーフティレベル（BSL）環境における動物モデルの統合は、感染モデルにおける免疫反応、肺病理、用量反応速度論に関するデータの解像度を高めています。

規制・倫理基準はどのように技術革新とコンプライアンスを推進しているのか？

厳しい規制の枠組みと進化する動物福祉基準は、前臨床呼吸・吸入システムのデザインと展開に影響を及ぼしています。FDA、EMA、OECDなどの機関は、粒子径分布、送達量、沈着プロファイルなどの吸入ドラッグデリバリーパラメータの詳細な特性評価を要求しています。その結果、前臨床試験装置メーカーは、トレーサブルなキャリブレーション、自動投与バリデーション、GLP準拠のソフトウェアプラットフォームを備えたバリデーション対応システムに投資しています。エアロゾル暴露システムは現在、長期の実験期間にわたって一貫した投与量を提供するために、リアルタイムのフィードバック制御をサポートするように設計されています。

動物福祉規制もまた、装置開発者に動物ストレスの軽減と暴露プロトコルの改良を促しています。ノーズオンリーシステムは、人間工学に基づいた拘束具と気流の乱れを最小限に抑え、不快感を軽減するよう再設計されています。全身チャンバーは現在、仕切られた気流ゾーンと環境エンリッチメント機能を備えています。さらに、3Rの原則（Replacement、Reduction、Refinement）により、必要な動物の数を最小限に抑えながらデータスループットを向上させるために、多動物テレメトリーシステムと多重化プレチスモグラフが奨励されています。このような規制遵守と倫理的設計の融合は、トランスレーショナルリサーチと前臨床検証用に調整された新世代の呼吸・吸入プラットフォームを推進しています。

前臨床呼吸・吸入実験装置の市場成長を加速させているものは？

世界の前臨床呼吸・吸入実験装置市場の成長は、標的肺治療薬に対する需要の高まり、吸入毒性学に対する規制の義務付け、呼吸器研究インフラへの世界の投資によってもたらされます。慢性呼吸器疾患や呼吸器感染症の急増は、大気汚染、喫煙、気候変動によってもたらされ、製薬企業やバイオテクノロジー企業が吸入薬剤製剤を優先するようになり、前臨床評価ツールの需要を押し上げています。COVID後の吸入抗ウイルス薬やワクチンへの研究開発投資は、この動向をさらに加速させています。

政府および学術機関は、特に北米、欧州、東アジアにおいて、エアロゾル毒性学、バイオエアロゾル封じ込め、呼吸器疾患モデリングのための研究所能力を拡大しています。吸入薬開発者は、CROと協力してデリバリーシステムを検証し、先端機器を使用して投与戦略を最適化しています。装置メーカーはまた、研究者が数値流体力学（CFD）や生理学的薬物動態（PBPK）モデルを使用してヒト薬物動態をシミュレーションできるように、ソフトウェアや分析プラットフォームとハードウェアをバンドルしています。

SCIREQ、Buxco/DSI（Harvard Bioscience）、CH Technologies、InExpose、Kent Scientificなどの主要企業は、統合吸入プラットフォーム、モジュール式曝露タワー、AI搭載分析スイートを含む製品ラインを拡大しています。規制当局の監視の高まり、医薬品パイプラインの多様化、呼吸器系の健康課題の蔓延の増加により、前臨床呼吸・吸入装置市場は製薬、環境、学術研究セクター全体で着実な成長を示すことになります。

セグメント

タイプ（呼吸装置、吸入装置）、エンドユーザー（CROおよび学術機関エンドユーザー、製薬およびバイオテクノロジー企業エンドユーザー）

調査対象企業の例

  • ADInstruments
  • Aeroqual Ltd
  • Buxco Research Systems（DSI）
  • Charles River Laboratories
  • CH Technologies（USA）, Inc.
  • Emka TECHNOLOGIES
  • Envigo（now part of Inotiv）
  • Harvard Apparatus
  • InExpose（Scireq）
  • Kent Scientific Corporation
  • La Jolla Alcohol Research, Inc.
  • LabLogic Systems Ltd
  • Med Associates Inc.
  • MGC Diagnostics Corporation
  • NoseOnly Research
  • PHYSIO-TECH Co., Ltd.
  • SciReq Inc.（Scientific Respiratory Equipment）
  • Somni Scientific
  • TSE Systems GmbH
  • VetEquip Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP37807

Global Preclinical Respiration and Inhalation Lab Equipment Market to Reach US$26.0 Million by 2030

The global market for Preclinical Respiration and Inhalation Lab Equipment estimated at US$20.3 Million in the year 2024, is expected to reach US$26.0 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Respiration Equipment, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$18.2 Million by the end of the analysis period. Growth in the Inhalation Equipment segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Million While China is Forecast to Grow at 4.2% CAGR

The Preclinical Respiration and Inhalation Lab Equipment market in the U.S. is estimated at US$5.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Preclinical Respiration and Inhalation Lab Equipment Market - Key Trends & Drivers Summarized

How Is Technology Enhancing Precision and Throughput in Respiratory and Inhalation Studies?

Preclinical respiration and inhalation lab equipment is undergoing rapid technological refinement to improve measurement accuracy, exposure control, and biological modeling. Advances in plethysmography systems, whole-body exposure chambers, nose-only exposure towers, and aerosol generators are enabling researchers to simulate human inhalation scenarios with higher precision and consistency. These systems now integrate high-resolution pressure sensors, differential flow meters, and real-time data acquisition software that can monitor tidal volume, breathing rate, minute ventilation, and peak expiratory flow in conscious rodents or anesthetized subjects.

Aerosol delivery systems are evolving with smart particle sizers, high-frequency ultrasonic nebulizers, and mass flow controllers that allow reproducible particle deposition across different regions of the respiratory tract. Novel systems also incorporate humidification and temperature regulation for physiologically relevant aerosol conditioning. Automated sampling and telemetry-enabled systems are being used to collect respiratory biomarkers, perform gas exchange measurements, and monitor respiratory depression or pulmonary irritation in response to drug candidates or environmental toxins. These technologies support both acute and chronic exposure protocols in preclinical pharmacokinetics, toxicology, and inhaled therapeutics development pipelines.

Which Research Domains Are Expanding the Use of Preclinical Respiratory Equipment?

While preclinical respiration equipment has long been used in pulmonary drug delivery studies, its applications are expanding across several interdisciplinary domains. In respiratory medicine R&D, these systems are central to evaluating efficacy and safety of inhaled corticosteroids, bronchodilators, and novel biologics for asthma, COPD, cystic fibrosis, and idiopathic pulmonary fibrosis. In oncology, inhaled formulations for chemotherapeutic delivery are being tested for site-specific deposition in lung tumors, supported by intratracheal and intranasal dosing rigs.

The equipment is also being used in environmental health studies to assess inhalation toxicity from air pollutants, nanoparticles, and industrial chemicals. Regulatory bodies such as OECD and U.S. EPA are increasingly emphasizing inhalation exposure studies in their guidelines for chemical risk assessment. Additionally, infectious disease researchers are employing nose-only exposure chambers and aerosolized pathogen systems to evaluate transmission and respiratory effects of airborne viruses and bacteria, including SARS-CoV-2, influenza, and tuberculosis. The integration of real-time respiratory telemetry with animal models in biosafety level (BSL) environments is enhancing the resolution of data on immune response, lung pathology, and dose-response kinetics in infectious models.

How Are Regulatory and Ethical Standards Driving Technological Innovation and Compliance?

Stringent regulatory frameworks and evolving animal welfare standards are influencing the design and deployment of preclinical respiratory and inhalation systems. Agencies such as the FDA, EMA, and OECD require detailed characterization of inhaled drug delivery parameters, including particle size distribution, delivered dose, and deposition profile. As a result, preclinical equipment manufacturers are investing in validation-ready systems with traceable calibration, automated dosing validation, and GLP-compliant software platforms. Aerosol exposure systems are now engineered to support real-time feedback control for consistent dose delivery over extended experimental periods.

Animal welfare regulations are also pushing equipment developers to reduce animal stress and refine exposure protocols. Nose-only systems are being redesigned with ergonomic restraints and minimal airflow turbulence to reduce discomfort. Whole-body chambers now include partitioned airflow zones and environmental enrichment features. Furthermore, the 3Rs principle (Replacement, Reduction, Refinement) is encouraging multi-animal telemetry systems and multiplexed plethysmographs to improve data throughput while minimizing the number of animals required. This convergence of regulatory compliance and ethical design is driving a new generation of respiratory and inhalation platforms tailored for translational research and preclinical validation.

What Is Accelerating Market Growth for Preclinical Respiration and Inhalation Lab Equipment?

The growth in the global preclinical respiration and inhalation lab equipment market is driven by rising demand for targeted pulmonary therapeutics, regulatory mandates for inhalation toxicology, and global investment in respiratory research infrastructure. The surge in chronic respiratory conditions and respiratory infections-compounded by air pollution, smoking, and climate change-is pushing pharmaceutical and biotech firms to prioritize inhaled drug formulations, driving demand for preclinical evaluation tools. Post-COVID R&D investments in inhaled antivirals and vaccines have further accelerated this trend.

Governments and academic institutions are expanding laboratory capacity for aerosol toxicology, bioaerosol containment, and respiratory disease modeling, especially in North America, Europe, and East Asia. Inhalation drug developers are collaborating with CROs to validate delivery systems and optimize dosing strategies using advanced equipment. Equipment manufacturers are also bundling hardware with software and analytics platforms that allow researchers to simulate human pharmacokinetics using computational fluid dynamics (CFD) and physiologically based pharmacokinetic (PBPK) models.

Key players such as SCIREQ, Buxco/DSI (Harvard Bioscience), CH Technologies, InExpose, and Kent Scientific are expanding their product lines to include integrated inhalation platforms, modular exposure towers, and AI-powered analytics suites. With rising regulatory scrutiny, drug pipeline diversification, and the growing prevalence of respiratory health challenges, the preclinical respiration and inhalation equipment market is set to witness steady growth across pharmaceutical, environmental, and academic research sectors.

SCOPE OF STUDY:

The report analyzes the Preclinical Respiration and Inhalation Lab Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Respiration Equipment, Inhalation Equipment); End-Use (CROs & Academic Institutes End-Use, Pharma & Biotech Companies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • ADInstruments
  • Aeroqual Ltd
  • Buxco Research Systems (DSI)
  • Charles River Laboratories
  • CH Technologies (USA), Inc.
  • Emka TECHNOLOGIES
  • Envigo (now part of Inotiv)
  • Harvard Apparatus
  • InExpose (Scireq)
  • Kent Scientific Corporation
  • La Jolla Alcohol Research, Inc.
  • LabLogic Systems Ltd
  • Med Associates Inc.
  • MGC Diagnostics Corporation
  • NoseOnly Research
  • PHYSIO-TECH Co., Ltd.
  • SciReq Inc. (Scientific Respiratory Equipment)
  • Somni Scientific
  • TSE Systems GmbH
  • VetEquip Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Preclinical Respiration and Inhalation Lab Equipment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Demand for Respiratory Disease Research Drives Investment in Preclinical Lab Equipment
    • Growth in Pulmonary Drug Delivery Studies Expands Addressable Market for Inhalation Exposure Systems
    • Rising Focus on Aerosol Toxicology Throws the Spotlight on Advanced Respiratory Testing Platforms
    • Regulatory Pressure for Inhalation Safety and Compliance Enhances Market for Certified Lab Systems
    • OEM Collaborations With CROs and Pharma Companies Strengthen Equipment Co-Development Pipelines
    • Technological Advancements in Nose-Only and Whole-Body Exposure Systems Propel Innovation
    • Expansion of COPD, Asthma, and Cystic Fibrosis Therapeutics Drives Respiratory Testing Equipment Demand
    • Push for Non-Clinical Safety Assessments Under GLP Guidelines Supports Equipment Standardization
    • Increased Use of Small Animal Models Promotes Need for Precision-Controlled Airflow and Dosimetry
    • Development of Automated Dose Generation and Monitoring Systems Enhances Lab Efficiency
    • Growing Interest in Inhaled Biologics and Nanoparticles Spurs Demand for Next-Gen Exposure Tools
    • Adoption of Real-Time Respiratory Monitoring and Tidal Volume Measurement Drives Data Quality
    • Rise in Toxicological Assessments for Industrial and Environmental Pollutants Supports Broader Applications
    • Surge in Preclinical Studies During Drug Discovery Phases Drives Equipment Procurement Cycles
    • Market Growth in Asia-Pacific Biomedical Research Accelerates Regional Lab Equipment Deployment
    • Integration With Data Acquisition and Analysis Software Strengthens Workflow Optimization
    • Focus on Animal Welfare and Minimally Invasive Monitoring Supports Innovation in Non-Lethal Protocols
    • Increased Emphasis on Personalized Drug Delivery Mechanisms Encourages Inhalation Studies
    • Expansion of Inhalation-Based Vaccines and Therapeutics Fuels Specialized Equipment Demand
    • Public and Private Sector Research Collaborations Promote Funding for Respiratory Lab Infrastructure
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preclinical Respiration and Inhalation Lab Equipment Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Respiration Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Respiration Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Respiration Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inhalation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Inhalation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for CROs & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for CROs & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for CROs & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: France 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Preclinical Respiration and Inhalation Lab Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Preclinical Respiration and Inhalation Lab Equipment by Type - Respiration Equipment and Inhalation Equipment Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by Type - Percentage Breakdown of Value Sales for Respiration Equipment and Inhalation Equipment for the Years 2014, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Preclinical Respiration and Inhalation Lab Equipment by End-Use - CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Preclinical Respiration and Inhalation Lab Equipment by End-Use - Percentage Breakdown of Value Sales for CROs & Academic Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION